Challenges in assessing statin-associated adverse events

Key Points

• To evaluate the challenges faced in assessing the adverse events linked to statin use.
• Conducted a randomized trial to evaluate adverse events
• Analyzed various assessment methodologies
• Identified risk factors influencing adverse event reporting
• Notable variability in reported adverse events across assessment methods
• Certain biomarkers linked to heightened risk of adverse effects
• Statins showed a statistically significant association with specific drug side effects